Page last updated: 2024-09-05

2-hexynyladenosine-5'-n-ethylcarboxamide and theophylline

2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with theophylline in 2 studies

Compound Research Comparison

Studies
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Trials
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Recent Studies (post-2010)
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Studies
(theophylline)
Trials
(theophylline)
Recent Studies (post-2010) (theophylline)
280220,0761,6121,383

Protein Interaction Comparison

ProteinTaxonomy2-hexynyladenosine-5'-n-ethylcarboxamide (IC50)theophylline (IC50)
Adenosine receptor A1Bos taurus (cattle)2.43

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C1
Baraldi, PG; Benini, A; Borea, PA; Cattabriga, E; Gessi, S; Klotz, KN; Lennan, SM; Leung, E; Merighi, S; Tabrizi, MA; Varani, K; Vincenzi, F1

Other Studies

2 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and theophylline

ArticleYear
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles

1997
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
    Biochemical pharmacology, 2005, Nov-25, Volume: 70, Issue:11

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Molecular Structure; Protein Binding; Receptor, Adenosine A2B; Recombinant Proteins

2005